PHARMACONTROL ApS: Financial statements 2023
CVR: 31074916
PHARMACONTROL ApS (CVR 31074916) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 1,447,018 and a net result of DKK 150,417 compared with DKK 278,332 the year before. That is an increase of 7.6% compared with the year before. Equity amounted to DKK 751,474. The solvency ratio was 60.1%. The company had 1 employee in the financial year.
- Gross Profit
- 1,447,018 kr.
- Profit/Loss
- 150,417 kr.
- Equity
- 751,474 kr.
- Total Assets
- 1,250,354 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 1.4 mio. | 150 t. | 751 t. | 1 |
| 2022 | - | 1.3 mio. | 278 t. | 801 t. | 1 |
| 2021 | - | 1.5 mio. | 167 t. | 523 t. | 1 |
| 2020 | - | 1.7 mio. | 122 t. | 556 t. | 1 |
| 2019 | - | 1.3 mio. | 31 t. | 534 t. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
PHARMACONTROL ApS has published its annual report for 2022. Gross profit came to DKK 1,344,674, and the net result was DKK 278,332.
About PHARMACONTROL ApS
PHARMACONTROL ApS is a Danish company of the type Anpartsselskab based in Holte, founded in 2007. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Carl Johan Dam Jensen. The company is owned by DAM JENSEN HOLDING ApS. The company has 4 employees. In 2025, the company reported a gross profit of DKK 1,032,293 and a net result of DKK 15,881 compared with DKK 269,844 the year before. Equity amounted to DKK 637,199.
